#1 choice worldwide in OA treatment (21)

Adverse events occurred at similar rates in patients treated with SUPARTZ FX and those treated with a saline placebo in an integrated analysis of 5 clinical studies. No serious injection site adverse events were reported and no allergic reactions due to SUPARTZ FX were reported. (12)

Total mg of HA per treatment course*




SUPARTZ FX has a high level of active ingredient for OA knee pain relief

SUPARTZ FX has 125 mg of active ingredient per 5-injection treatment course. With 300 million injections worldwide (19), it has no pseudoseptic adverse events based on PMA Integrated Analysis. (18)*

*Does not include current prescribing experience.
All trademarks are the properties of their respective companies.

SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found here or by contacting customer service at